Monday, October 31, 2005

FDA approves Soltamox, an experimental cancer drug, for breast cancer

Business Week Online, October 31, 2005
Savient Pharmaceuticals Inc. said regulators approved its experimental cancer drug as a treatment for breast cancer. Soltamox -- is the first oral liquid version of the tamoxifen cancer treatment to be approved in the United States. The drug is already sold in Britain, Ireland and Germany


Post a Comment

<< Home

/* WebRing Code */